Sort
10,766 grants matching “checkpoint inhibitor”
Molecular Targeted Radionuclide Therapy to Enhance Tumor Cell Susceptibility and Response to Immune Checkpoint Inhibition
$392,015Zachary Scott Morris · University Of Wisconsin-Madison · P01 · FY2021 · CA
Implications of the ATR Checkpoint Kinase in Radiation and Targeted Therapies
$391,954Lee Zou · Massachusetts General Hospital · R01 · FY2020 · CA
Retroviral RLI immunomodulatory gene therapy for glioblastoma
$391,638Manish Aghi · University Of California, San Francisco · R01 · FY2024 · NS
ST8Sia6 expression on tumors inhibits the immune response
$391,416Virginia Smith Shapiro · Mayo Clinic Rochester · R01 · FY2023 · CA
ST8Sia6 expression on tumors inhibits the immune response
$391,416Virginia Smith Shapiro · Mayo Clinic Rochester · R01 · FY2022 · CA
Regulation of Chromosome Segregation in Human Cells
$391,345Prasad V Jallepalli · Sloan-Kettering Inst Can Research · R01 · FY2010 · GM
Targeting tumor innate immune signaling in pancreatic cancer
$391,277Kian H Lim · Washington University · R01 · FY2025 · CA
Functional Analysis of p53 Polymorphic Variants
$391,227Maureen E Murphy · Wistar Institute · R01 · FY2021 · CA
Functional Analysis of p53 Polymorphic Variants
$391,227Maureen E Murphy · Wistar Institute · R01 · FY2023 · CA
Functional Analysis of p53 Polymorphic Variants
$391,227Maureen E Murphy · Wistar Institute · R01 · FY2025 · CA
Dual-pronged nano-drug delivery using plant virus-like particles
$391,196Nicole Franziska Steinmetz · University Of California, San Diego · R01 · FY2022 · CA
Small Molecule Activators of Procaspases as Anti-Cancer Agents
$391,184Paul Hergenrother · University Of Illinois At Urbana-Champaign · R01 · FY2019 · CA
Integration of neo-antigen vaccines and immune checkpoint therapy
$391,107Elizabeth Marion Jaffee · Johns Hopkins University · P01 · FY2021 · CA
Integration of neo-antigen vaccines and immune checkpoint therapy
$391,107Elizabeth Marion Jaffee · Johns Hopkins University · P01 · FY2025 · CA
Molecular Targeted Radionuclide Therapy to Enhance Tumor Cell Susceptibility and Response to Immune Checkpoint Inhibition
$390,879Zachary Scott Morris · University Of Wisconsin-Madison · P01 · FY2020 · CA
Pro-tumor functions of neutrophils in squamous cell lung cancer
$390,763Trudy Gale Oliver · Duke University · R01 · FY2024 · CA
Targeted MEK inhibition to enhance immunotherapy in cholangiocarcinoma
$390,583Gregory B. Lesinski · Emory University · R01 · FY2019 · CA
Administrative Supplement to 5DP1DA043893
$390,537Peter S Kim · Stanford University · DP1 · FY2018 · DA
Mechanism and therapeutic potential of microglia regulation in glioblastoma
$390,425Peiwen Chen · Cleveland Clinic Lerner Com-Cwru · R01 · FY2024 · NS
DEREGULATION OF CELLULAR IKB KINASES BY HTLV1 TAX
$390,256Vanderbilt University · R01 · FY2003 · CA
BET protein antagonist-based targeted therapy of Mantle Cell Lymphoma
$390,134Kapil N. Bhalla · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA
BET protein antagonist-based targeted therapy of Mantle Cell Lymphoma
$390,134Kapil N. Bhalla · University Of Tx Md Anderson Can Ctr · R01 · FY2018 · CA
BET protein antagonist-based targeted therapy of Mantle Cell Lymphoma
$390,134Kapil N. Bhalla · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · CA
BET protein antagonist-based targeted therapy of Mantle Cell Lymphoma
$390,134Kapil N. Bhalla · University Of Tx Md Anderson Can Ctr · R01 · FY2017 · CA
Project 2: Reversing STING-mediated immunosuppression in LKB1-mutant lung adenocarcinoma
$390,089Haian Fu · Emory University · P01 · FY2023 · CA